Hologic Closes $350M Gynesonics AcquisitionHologic Closes $350M Gynesonics Acquisition

Hologic has closed the $350 million acquisition of Gynesonics, which develops minimally invasive solutions for women.

The Marlborough, MA-based company first announced the deal in October of 2024 during a somewhat healthy period of M&A. Medtech deals lagged behind in 2023 but saw a tremendous boost in 2024.   
Gynesonics has developed the Sonata System, a technology intended for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incision-less procedure.
“We are excited to complete the acquisition of Gynesonics and to increase access to their Sonata System, which complements and expands our range of minimally invasive solutions for heavy periods and fibroids,” said Brandon Schnittker, President of Surgical Solutions at Hologic. “As global champions for women’s health, we are dedicated to empowering surgeons with diverse, cutting-edge treatment options as we strive to transform women’s lives for the better.”

The deal closure follows Hologic's October notification to the Connecticut Department of Labor of the intent to lay off 86 employees from Dec. 20 through 1Q25 at its closing Danbury, CT facility.

Related:What Medtech Is Talking About in January